Frédéric Dayan
Impact in
- Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism
- Molecular Biology top 5%
- Enzyme function and inhibition
- Angiogenesis and VEGF in Cancer
Papers in
-
- Cancer, Hypoxia, and Metabolism 9
-
- Pharmaceutical studies and practices 4
- Co-authors
- Jacques Pouysségur (10 shared papers)Nathalie M. Mazure (8 shared papers)M. Christiane Brahimi-Horn (4 shared papers)Eric Trottier (2 shared papers)Julie Laferrière (2 shared papers)Karine Ilc (2 shared papers)Johanna Chiche (1 shared paper)Danièle Roux (3 shared papers)
In The Last Decade
Frédéric Dayan
17 papers receiving 2.8k citations
Frédéric Dayan's Hit Papers
Peers
Comparison fields: 5 of 95
- Cancer Research 1.2k
- Molecular Biology 1k
- Oncology 275
- Genetics 80
- Biomaterials 68
Countries citing papers authored by Frédéric Dayan
This map shows the geographic impact of Frédéric Dayan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Dayan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Dayan more than expected).
Fields of papers citing papers by Frédéric Dayan
This network shows the impact of papers produced by Frédéric Dayan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Dayan. The network helps show where Frédéric Dayan may publish in the future.
Co-authors
The 25 scholars most cited alongside Frédéric Dayan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Hypoxia signalling in cancer and approaches to enforce tumour regression Hit paper breakdown → | 2006 | 1452 |
| 2 | 2008 | 644 | |
| 3 | 2006 | 247 | |
| 4 | 2011 | 139 | |
| 5 | 2004 | 128 | |
| 6 | 2008 | 79 | |
| 7 | 2008 | 44 | |
| 8 | 2009 | 40 | |
| 9 | 2012 | 35 | |
| 10 | 2011 | 34 | |
| 11 | 2019 | 21 | |
| 12 | 2022 | 7 | |
| 13 | 2023 | 6 | |
| 14 | 2023 | 6 | |
| 15 | 2006 | 2 | |
| 16 | 2023 | 2 | |
| 17 | 2024 | 2 |
About Frédéric Dayan
Frédéric Dayan is a scholar working on Cancer Research, Pediatrics, Perinatology and Child Health, Pharmacology, Statistics and Probability and Computational Theory and Mathematics, having authored 17 papers that have together received 2.9k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (9 papers), Pharmaceutical studies and practices (4 papers), Gene Regulatory Network Analysis (1 paper), Pharmacogenetics and Drug Metabolism (1 paper), Statistical Methods in Clinical Trials (1 paper), Bipolar Disorder and Treatment (1 paper), Computational Drug Discovery Methods (1 paper) and Cardiac electrophysiology and arrhythmias (1 paper). The work is most often cited by research in Cancer Research (1.2k citations), Molecular Biology (1k citations), Oncology (275 citations), Genetics (80 citations) and Biomaterials (68 citations). Frédéric Dayan has collaborated with scholars based in France and Spain. Frequent co-authors include Jacques Pouysségur, Nathalie M. Mazure, M. Christiane Brahimi-Horn, Eric Trottier, Julie Laferrière, Karine Ilc, Johanna Chiche, Danièle Roux, Rebecca L. Bilton and Jérôme Durivault. Their work appears in journals such as Cancer Research, Pharmaceuticals, Journal of Theoretical Biology, Cancer Microenvironment and Nature.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.